Funder
National Natural Science Foundation of China
NIH/NIAID
NIH F31
CHRP
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference43 articles.
1. Novel therapeutic strategies targeting HIV integrase
2. HIV-1 Integrase: Mechanism and Inhibitor Design;Neamati,2011
3. Molecular mechanisms in retrovirus DNA integration
4. HIV Integrase Inhibitors: From Diketoacids to Heterocyclic Templates: A History of HIV Integrase Medicinal Chemistry at Merck West Point and Merck Rome (IRBM) Leading to the Discovery of Raltegravir;Egbertson,2011
5. Discovery of Raltegravir, a Potent, Selective Orally Bioavailable HIV-Integrase Inhibitor for the Treatment of HIV-AIDS Infection
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献